HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Natural Beauty Big Leaguer L’Occitane Acquires No. 1 In British Luxury Skin Care

Executive Summary

L’Occitaine’s $900m Elemis buy will build out the manufacturer/retailer’s premium, natural-oriented beauty portfolio, adding a prestige brand that aspires to be a leader in global skin care with its nature/science balance and cross-generational consumer appeal.

You may also be interested in...



L’Oreal Paris League Of Experts; ELC Names Tom Ford Leaders; Every Man Jack Gets B Corp Certified; Cosmetics News

“Establishing a collective will allow us to better reach and engage with our consumers in a way that feels approachable and relatable,” says L’Oreal Paris US, which has brought on prominent makeup artists Allan Avendaño, Claudia Betancur, and Erica Taylor as the first members of its League of Experts. More cosmetics news.

Inter Parfums Expects ‘Another Spectacular Year’ As Prestige Fragrance Boom Continues

The New York-based firm recorded 24% growth in fiscal 2023 first-quarter net sales to $311.7m. The performance reflects growth across all regions as consumers continue to splurge on more expensive fragrances in larger sizes, a trend that arose at the height of the global pandemic.

EU To Provide Guidance On New Endocrine Disruptor, Persistent Chemicals Hazard Classes In 2024

Industry should use existing guidance for the identification of endocrine disruptors until the European Chemicals Agency updates Guidance on the Application of the CLP Criteria, targeted for mid-2024. Transition periods will begin elapsing in May 2025 when new substances on the market must be compliant with the new hazard communication requirements, followed by new mixtures in May 2026.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS148445

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel